Skip to main content
. 2022 Jul 27;13(3):632–640. doi: 10.1055/s-0042-1750416

Table 2. Differences in primary and secondary outcomes at discharge and 30-day follow-up.

Control group Intervention group p-Value
Primary outcome ( n = 497) ( n = 513)
 gLOS, days, median [IQR] 3.23 [1.75–6.00] 3.18 [1.76–5.95] 0.8
Secondary outcome ( n = 497) ( n = 513)
 LOS, days, median [IQR] 4.50 [2.34–7.65] 4.20 [2.33–7.51] 0.8
Adverse safety outcomes in scored patients discharged alive. ( n  = 640) ( n  = 661)
 30-d re-presentation, no (%) 115 (18.0%) 138 (20.9%) 0.2
 30-d mortality, no (%) 3 (0.47%) 8 (1.2%) 0.2
Adverse safety outcomes in all scored patients. ( n  = 702) ( n  = 713)
 Inpatient mortality/hospice, no (%) 63 (9.0%) 50 (7.0%) 0.2
 Any adverse outcome, no (%) 178 (25.3%) 191 (26.8%) 0.6

Abbreviations: gLOS, length of stay after first green score; LOS, length of stay; IQR, interquartile range.